Development of RIV-5061- A Prototype Nomethiazole for the Enhancement of Cognitive Function
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Revivo Therapeutics, Inc
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
T Douglas Cowart
Fiscal Year
2018
Region
Research Triangle
Project Description:
Revivo Therapeutics is developing a novel class of drugs to treat Alzheimer's Disease (AD) that provide both symptomatic relief and slow the progression of disease. The company will complete pre-clinical studies necessary to initiate clinical studies for the treatment of mild-to-moderate cognitive impairment in AD patients.